SEC Comment Letter for ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV) — Jul 31, 2019
ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: July 31, 2019 · CIK: 0000949858 · Accession: 0000000000-19-011881
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232817
Letter
July 31, 2019 Richard Stewart Chief Executive Officer Achieve Life Sciences, Inc. 1040 West Georgia Street, Suite 1030 Vancouver, British Columbia, V6E 4H1 Re:Achieve Life Sciences, Inc. Registration Statement on Form S-1 Filed July 25, 2019 File No. 333-232817 Dear Mr. Stewart: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Amanda Rose, Esq.
Show Raw Text
July 31, 2019
Richard Stewart
Chief Executive Officer
Achieve Life Sciences, Inc.
1040 West Georgia Street, Suite 1030
Vancouver, British Columbia, V6E 4H1
Re:Achieve Life Sciences, Inc.
Registration Statement on Form S-1
Filed July 25, 2019
File No. 333-232817
Dear Mr. Stewart:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Amanda Rose, Esq.